maria eugenia hernandez

Dr. maria eugenia hernandez

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2015 in Journal of Biomedical Science
Verified
Journal Article
Open access
PDF file
NHNancy G. Hernandez-Chan
Nancy G. Hernandez-Chan
MBMichael Bannon
Michael Bannon
COCarlos Enrique Orozco-Barrios
Carlos Enrique Orozco-Barrios
LELourdes Escobedo
Lourdes Escobedo
SZSergio R Zamudio
Sergio R Zamudio
DMDaniel Martinez-Fong
Daniel Martinez-Fong
The neurotrophin Brain-Derived Neurotrophic Factor (BDNF) influences nigral dopaminergic neurons via autocrine and paracrine mechanisms. The reduction of BDNF expression in Parkinson’s disease substantia nigra (SN) might contribute to the death of dopaminergic neurons because inhibiting BDNF expression in the SN causes parkinsonism in the rat. This study aimed to demonstrate that increasing BDNF expression in dopaminergic neurons of rats with one week of 6-hydroxydopamine lesion recovers from parkinsonism. The plasmids phDAT-BDNF-flag and phDAT-EGFP, coding for enhanced green fluorescent protein, were transfected using neurotensin (NTS)-polyplex, which enables delivery of genes into the dopaminergic neurons via neurotensin-receptor type 1 (NTSR1) internalization. Two weeks after transfections, RT-PCR and immunofluorescence techniques showed that the residual dopaminergic neurons retain NTSR1 expression and susceptibility to be transfected by the NTS-polyplex. phDAT-BDNF-flag transfection did not increase dopaminergic neurons, but caused 7-fold increase in dopamine fibers within the SN and 5-fold increase in innervation and dopamine levels in the striatum. These neurotrophic effects were accompanied by a significant improvement in motor behavior. NTS-polyplex-mediated BDNF overexpression in dopaminergic neurons has proven to be effective to remit hemiparkinsonism in the rat. This BDNF gene therapy might be helpful in the early stage of Parkinson’s disease.

18 December 2018 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
GPGilberto Pérez-Sánchez
Gilberto Pérez-Sánchez
Enrique Becerril VillanuevaEnrique Becerril Villanueva
Enrique Becerril Villanueva
RARodrigo Arreola
Rodrigo Arreola
GMGabriela Martínez-Levy
Gabriela Martínez-Levy
MHmaria eugenia hernandez
maria eugenia hernandez
Lenin PavónLenin Pavón
Lenin Pavón
Changes in cytokine levels in major depression and during treatment have been reported in adults. However, few studies have examined cytokine levels in an adolescent sample despite this being a common age of onset.Methods. We measured proinflammatory (IL-2, IFN-γ, IL-1β, TNF-α, IL-6, IL-12, and IL-15) and anti-inflammatory (IL-4, IL-5, IL-13, IL-1Ra, and IL-10) cytokine serum levels in 22 adolescents with major depression and 18 healthy volunteers. Cytokines were measured by multiplex bead-based immunoassays at baseline, and 4 and 8 weeks after commencement of fluoxetine administration in the clinical group.Results. Compared to healthy volunteers, adolescents with major depression at baseline showed significant increases in all pro- and anti-inflammatory cytokines, except IL-1Ra and IL-10. Significant changes were observed in fluoxetine treatment compared to baseline: proinflammatory cytokines IFN-γ, IL-1β, TNF-α, IL-6, IL-12, and IL-15 were decreased only at week 4 whereas IL-2 was increased only at week 8; anti-inflammatory cytokines IL-4 and IL-5 were increased at week 8 while IL-1Ra was reduced only at week 4. There were no significant correlations between cytokine levels and symptomatic improvement in HDRS.Discussion. The results suggest a significant interplay between cytokine levels, the depressive state, and the stage of treatment with an SSRI. To the best of our knowledge, this is the first report in depressed adolescents with elevated IL-12, IL-13, and IL-15 levels. Further studies are necessary to clarify the role and mechanisms of altered cytokine levels in the pathogenesis and physiopathology of major depressive disorder.

3 June 2010 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
MHmaria eugenia hernandez
maria eugenia hernandez
Enrique Becerril VillanuevaEnrique Becerril Villanueva
Enrique Becerril Villanueva
MPMayra Perez
Mayra Perez
Philippe LeffPhilippe Leff
Philippe Leff
BABenito Anton
Benito Anton
Lenin PavónLenin Pavón
Lenin Pavón
Fibromyalgia (FM) is characterized by chronic, widespread muscular pain and tenderness and is generally associated with other somatic and psychological symptoms. Further, circulatory levels of proinflammatory cytokines (IL-1β, TNF-α, and IL-6) may be altered in FM patients, possibly in association with their symptoms. Recently, rises in BMI have been suggested to contribute to increased circulating levels of proinflammatory cytokines in FM patients. Our aim was to measure the circulatory levels of proinflammatory cytokines to determine the influence of BMI on these levels in FM patients and healthy volunteers (HVs). In Spanish FM patients (n = 64) and HVs (n = 25), we measured BMI and serum concentrations of proinflammatory cytokines by capture ELISA.

14 May 2018 in BioMed Research International
Verified
Journal Article
Open access
PDF file
ECElvia Coballase
Elvia Coballase
LNLuz Navarro
Luz Navarro
JOJ. L. Ortiz
J. L. Ortiz
LVL. Verdugo-Díaz
L. Verdugo-Díaz
Juan Manuel GALLARDOJuan Manuel GALLARDO
Juan Manuel GALLARDO
FEF. Estrada-Rojo
F. Estrada-Rojo
Stress is a state of vulnerable homeostasis that alters the physiological and behavioral responses. Stress induces oxidative damage in several organs including the brain, liver, kidney, stomach, and heart. Preliminary findings suggested that the magnetic stimulation could accelerate the healing processes and has been an effective complementary therapy in different pathologies. However, the mechanism of action of static magnetic fields (SMFs) is not well understood. In this study, we demonstrated the effects of static magnetic fields (0.8 mT) in a restraint stressed animal model, focusing on changes in different markers of oxidative damage. A significant increase in the plasma levels of nitric oxide (NO), malondialdehyde (MDA), and advanced oxidation protein products (AOPP), and a decrease in superoxide dismutase (SOD), glutathione (GSH), and glycation end products (AGEs) were observed in restraint stress model. Exposure to SMFs over 5 days (30, 60, and 240 min/day) caused a decrease in the NO, MDA, AGEs, and AOPP levels; in contrast, the SOD and GSH levels increased. The response to SMFs was time-dependent. Thus, we proposed that exposure to weak-intensity SMFs could offer a complementary therapy by attenuating oxidative stress. Our results provided a new perspective in health studies, particularly in the context of oxidative stress.

1 September 2016 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
JBJorge Alberto Barrios-Payán
Jorge Alberto Barrios-Payán
ARAlberto Revuelta
Alberto Revuelta
DMDulce Mata-Espinosa
Dulce Mata-Espinosa
BMBrenda Marquina-Castillo
Brenda Marquina-Castillo
Enrique Becerril VillanuevaEnrique Becerril Villanueva
Enrique Becerril Villanueva
Rogelio Hernández-PandoRogelio Hernández-Pando
Rogelio Hernández-Pando

6 December 2021 in Toxics
Verified
Journal Article
Open access
PDF file
TLTeresita Guadalupe López-Aceves
Teresita Guadalupe López-Aceves
ECElvia Coballase
Elvia Coballase
FEFrancisco Estrada-Rojo
Francisco Estrada-Rojo
AVAmerica Vanoye-carlo
America Vanoye-carlo
LCLiliana Carmona-Aparicio
Liliana Carmona-Aparicio
CLClaudia León-Sicairos
Claudia León-Sicairos
Permethrin (PERM) is a member of the class I family of synthetic pyrethroids. Human use has shown that it affects different systems, with wide health dysfunctions. Our aim was to determine bioenergetics, neuroinflammation and morphology changes, as redox markers after subacute exposure to PERM in rats. We used MDA determination, protein carbonyl assay, mitochondrial O2 consumption, expression of pro-inflammatory cytokines and a deep histopathological analysis of the hippocampus. PERM (150 mg/kg and 300 mg/kg body weight/day, o.v.) increased lipoperoxidation and carbonylated proteins in a dose-dependent manner in the brain regions. The activities of antioxidant enzymes glutathione peroxidase, reductase, S-transferase, catalase, and superoxide dismutase showed an increase in all the different brain areas, with dose-dependent effects in the cerebellum. Cytokine profiles (IL-1β, IL-6 and TNF-α) increased in a dose-dependent manner in different brain tissues. Exposure to 150 mg/kg of permethrin induced degenerated and/or dead neurons in the rat hippocampus and induced mitochondrial uncoupling and reduction of oxidative phosphorylation and significantly decreased the respiratory parameters state 3-associated respiration in complex I and II. PERM exposure at low doses induces reactive oxygen species production and imbalance in the enzymatic antioxidant system, increases gene expression of pro-inflammatory interleukins, and could lead to cell damage mediated by mitochondrial functional impairment.